LTC:NYE-LTC Properties Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 39

Change

+0.92 (+2.42)%

Market Cap

USD 1.56B

Volume

0.42M

Analyst Target

USD 35.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

LTC is a real estate investment trust (REIT) investing in seniors housing and health care properties primarily through sale-leasebacks, mortgage financing, joint-ventures and structured finance solutions including preferred equity and mezzanine lending. LTC's investment portfolio includes 201 properties in 26 states with 29 operating partners. Based on its gross real estate investments, LTC's investment portfolio is comprised of approximately 50% seniors housing and 50% skilled nursing properties.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+1.11 (+0.81%)

USD 81.50B
VTR Ventas Inc

+0.45 (+0.68%)

USD 27.31B
DOC Healthpeak Properties Inc

+0.20 (+0.89%)

USD 16.16B
CTRE CareTrust REIT Inc.

+0.89 (+2.79%)

USD 4.68B
AHR American Healthcare REIT, Inc.

+0.62 (+2.35%)

USD 4.03B
NHI National Health Investors Inc

+0.98 (+1.27%)

USD 3.32B
UHT Universal Health Realty Income..

+0.43 (+1.08%)

USD 0.57B
CHCT Community Healthcare Trust Inc

+1.19 (+6.70%)

USD 0.49B
GMRE-PA Global Medical REIT Inc

+0.05 (+0.20%)

USD 0.41B
GMRE Global Medical REIT Inc

+0.07 (+0.76%)

N/A

ETFs Containing LTC

ZPRG:F SPDR S&P Global Dividend .. 2.45 % 0.00 %

-0.22 (-0.33%)

USD 1.04B
ZPRG:XETRA SPDR S&P Global Dividend .. 2.45 % 0.00 %

-0.13 (-0.33%)

USD 1.04B
GLDV:SW SPDR® S&P Global Dividen.. 2.45 % 0.00 %

-0.10 (-0.33%)

USD 1.29B
WDIV SPDR® S&P Global Dividen.. 1.57 % 0.40 %

-0.05 (-0.33%)

USD 0.20B
WDIV:AU SPDR S&P Global Dividend 1.52 % 0.00 %

-0.07 (-0.33%)

USD 0.28B
XSLV Invesco S&P SmallCap Low .. 1.08 % 0.25 %

+0.03 (+-0.33%)

USD 0.31B
HIPS GraniteShares HIPS US Hig.. 0.00 % 0.70 %

+0.07 (+-0.33%)

N/A
SRET Global X SuperDividend® .. 0.00 % 0.59 %

+0.27 (+-0.33%)

USD 0.22B
GBDV:LSE SPDR S&P Global Dividend .. 0.00 % 0.00 %

+0.02 (+-0.33%)

N/A
GLDV:LSE SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

+0.02 (+-0.33%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.42% 50% F 79% B-
Dividend Return -122.76% 50% F 28% F
Total Return -101.34% 7% C- 5% F
Trailing 12 Months  
Capital Gain 22.95% 50% F 61% D-
Dividend Return -123.11% 50% F 31% F
Total Return -100.16% 7% C- 4% F
Trailing 5 Years  
Capital Gain -22.68% 38% F 28% F
Dividend Return -59.34% 50% F 47% F
Total Return -82.02% 8% B- 10% F
Average Annual (5 Year Horizon)  
Capital Gain -2.59% 43% F 23% F
Dividend Return 3.11% 36% F 38% F
Total Return 5.70% 57% F 86% B+
Risk Return Profile  
Volatility (Standard Deviation) 16.47% 79% B- 62% D
Risk Adjusted Return 18.85% 43% F 37% F
Market Capitalization 1.56B 40% F 64% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.